Literature DB >> 7679217

Cyclic amphipathic peptide-DNA complexes mediate high-efficiency transfection of adherent mammalian cells.

J Y Legendre1, F C Szoka.   

Abstract

A DNA transfection protocol has been developed that makes use of the cyclic cationic amphipathic peptide gramicidin S and dioleoyl phosphatidylethanolamine. The DNA complex is formed by mixing gramicidin S with DNA at a 1:1 charge ratio and then adding phosphatidylethanolamine at a lipid/peptide molar ratio of 5:1. The complex mediates rapid association of DNA with cells and leads to transient expression levels of beta-galactosidase ranging from 1 to 30% of the transfected cells, with long-term expression being about an order of magnitude lower. The respective roles of peptide and phospholipid are not yet resolved but optimal transfection requires both the cyclic peptide and the hexagonal phase-competent phospholipid PtdEtn. Transfection in CV-1 cells is not affected by lysomotrophic agents, which suggests that DNA entry into the cell is via the plasma membrane. This technique that is simple, economical, and reproducible mediates transfection levels up to 20-fold higher than cationic liposomes in adherent mammalian cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7679217      PMCID: PMC45776          DOI: 10.1073/pnas.90.3.893

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.

Authors:  P L Felgner; T R Gadek; M Holm; R Roman; H W Chan; M Wenz; J P Northrop; G M Ringold; M Danielsen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

2.  Receptor-mediated gene delivery and expression in vivo.

Authors:  G Y Wu; C H Wu
Journal:  J Biol Chem       Date:  1988-10-15       Impact factor: 5.157

3.  pH-sensitive immunoliposomes mediate target-cell-specific delivery and controlled expression of a foreign gene in mouse.

Authors:  C Y Wang; L Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

4.  Construction of plasmids that express E. coli beta-galactosidase in mammalian cells.

Authors:  G R MacGregor; C T Caskey
Journal:  Nucleic Acids Res       Date:  1989-03-25       Impact factor: 16.971

5.  Lateral diffusion of a hydrophobic peptide, N-4-nitrobenz-2-oxa-1,3-diazole gramicidin S, in phospholipid multibilayers.

Authors:  E S Wu; K Jacobson; F Szoka; A Portis
Journal:  Biochemistry       Date:  1978-12-12       Impact factor: 3.162

6.  Complexation and phase transfer of nucleic acids by gramicidin S.

Authors:  E M Krauss; S I Chan
Journal:  Biochemistry       Date:  1984-01-03       Impact factor: 3.162

7.  Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

Authors:  P J Southern; P Berg
Journal:  J Mol Appl Genet       Date:  1982

8.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

9.  Destabilization of phosphatidylethanolamine liposomes at the hexagonal phase transition temperature.

Authors:  H Ellens; J Bentz; F C Szoka
Journal:  Biochemistry       Date:  1986-01-28       Impact factor: 3.162

10.  Action mechanism of amphipathic peptides gramicidin S and melittin on erythrocyte membrane.

Authors:  T Katsu; C Ninomiya; M Kuroko; H Kobayashi; T Hirota; Y Fujita
Journal:  Biochim Biophys Acta       Date:  1988-03-22
View more
  17 in total

1.  Interaction of cationic colloids at the surface of J774 cells: a kinetic analysis.

Authors:  P Chenevier; B Veyret; D Roux; N Henry-Toulmé
Journal:  Biophys J       Date:  2000-09       Impact factor: 4.033

Review 2.  Applications of biological pores in nanomedicine, sensing, and nanoelectronics.

Authors:  Sheereen Majd; Erik C Yusko; Yazan N Billeh; Michael X Macrae; Jerry Yang; Michael Mayer
Journal:  Curr Opin Biotechnol       Date:  2010-06-18       Impact factor: 9.740

3.  A physicochemical approach for predicting the effectiveness of peptide-based gene delivery systems for use in plasmid-based gene therapy.

Authors:  J G Duguid; C Li; M Shi; M J Logan; H Alila; A Rolland; E Tomlinson; J T Sparrow; L C Smith
Journal:  Biophys J       Date:  1998-06       Impact factor: 4.033

Review 4.  Hydrophobic ion pairing: altering the solubility properties of biomolecules.

Authors:  J D Meyer; M C Manning
Journal:  Pharm Res       Date:  1998-02       Impact factor: 4.200

Review 5.  Pharmaceutical approach to somatic gene therapy.

Authors:  F D Ledley
Journal:  Pharm Res       Date:  1996-11       Impact factor: 4.200

6.  Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: a stage toward artificial viruses.

Authors:  J S Remy; A Kichler; V Mordvinov; F Schuber; J P Behr
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

7.  Synthesis and in vitro testing of new potent polyacridine-melittin gene delivery peptides.

Authors:  Nicholas J Baumhover; Kevin Anderson; Christian A Fernandez; Kevin G Rice
Journal:  Bioconjug Chem       Date:  2010-01       Impact factor: 4.774

8.  Cationic facial amphiphiles: a promising class of transfection agents.

Authors:  S Walker; M J Sofia; R Kakarla; N A Kogan; L Wierichs; C B Longley; K Bruker; H R Axelrod; S Midha; S Babu; D Kahne
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

9.  The role of helper lipids in cationic liposome-mediated gene transfer.

Authors:  S W Hui; M Langner; Y L Zhao; P Ross; E Hurley; K Chan
Journal:  Biophys J       Date:  1996-08       Impact factor: 4.033

10.  Epithelial cell specific properties and genetic complementation in a delta F508 cystic fibrosis nasal polyp cell line.

Authors:  K Kunzelmann; D C Lei; K Eng; L C Escobar; T Koslowsky; D C Gruenert
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-09       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.